What anesthetic should be given to a patient prior to intralesional injection of triamcinolone into a keloid scar?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anesthetic for Intralesional Triamcinolone Injection into Keloid Scars

Topical lidocaine (60% lidocaine tape or EMLA cream containing lidocaine plus prilocaine) applied for at least 2 hours before injection is the most effective approach for reducing needle-stick pain during intralesional triamcinolone injection for keloid treatment.

Primary Recommendation: Topical Anesthesia

Topical lidocaine preparations should be the first-line anesthetic choice for intralesional keloid injections based on the following evidence:

  • 60% lidocaine tape applied for ≥120 minutes before injection reduces pain scores from 82.6 mm to 18.9 mm on a 100-mm visual analog scale, with 71.4% of patients tolerating treatment well 1

  • Topical anesthetics (EMLA cream or similar) significantly reduce needle-stick pain compared to no anesthesia or lidocaine mixing, particularly effective for sternum and auricular keloids 2

  • The Infectious Diseases Society of America guidelines recommend EMLA cream (lidocaine plus prilocaine) as local anesthesia for intralesional injections, noting that young children may need general anesthesia for the procedure 3

Why NOT to Mix Lidocaine with Triamcinolone

Mixing 1% lidocaine with triamcinolone in a 1:1 ratio does NOT effectively reduce injection pain and should be avoided:

  • A randomized controlled trial demonstrated that lidocaine mixed with triamcinolone failed to alleviate pain during the actual injection (VAS scores 4.97 for control vs 4.97 for lidocaine mixture) 2

  • While lidocaine mixing reduces needle-stick pain slightly, it provides no benefit for the more significant injection pain that occurs during infiltration 2

  • Diluting triamcinolone with lidocaine may reduce the effective concentration of corticosteroid delivered to the keloid tissue 4

Practical Application Protocol

For optimal pain control, follow this approach:

  • Apply 60% lidocaine tape or EMLA cream to the keloid surface at least 2 hours before the procedure (ideally 2-4 hours) 1, 3

  • Use occlusion to enhance penetration of the topical anesthetic 1

  • Inject triamcinolone acetonide at 10-40 mg/mL concentration (typically 20 mg/mL for keloids) just beneath the dermis in the upper subcutis 5, 6

  • Inject 0.05-0.1 mL per injection site to achieve therapeutic effect 5

  • Repeat injections every 3-4 weeks as needed 5, 6

Important Safety Considerations

Monitor for local anesthetic toxicity when using topical preparations:

  • Avoid applying topical lidocaine to large surface areas or for prolonged periods beyond recommended duration 3

  • Be aware that anaphylaxis to triamcinolone acetonide can occur with repeated injections, even after years of uneventful use 7

  • Common adverse effects include skin atrophy, telangiectasias, and pigmentary changes at injection sites, which are dose-dependent 5, 4

Alternative Considerations for Severe Cases

For patients who cannot tolerate the procedure despite topical anesthesia:

  • General anesthesia may be necessary for young children or patients with extensive keloids requiring multiple injection sites 3

  • Consider regional nerve blocks for keloids in anatomically appropriate locations, though this requires waiting 4 hours before or after any local anesthetic intervention 3

References

Research

A Topical Anesthetic and Lidocaine Mixture for Pain Relief During Keloid Treatment: A Double-Blind, Randomized Controlled Trial.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Corticosteroid-Responsive Dermatoses

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Intralesional Kenalog for Localized Skin Inflammation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.